reports
Moody's Ratings says that Merck's acquisition of Terns adds a high-ups...
Announcement: Moody's Ratings says that Merck's acquisition of Terns adds a high-upside leukemia candidate with clinical execution risk. Global Credit Research- 26 Mar 2026. New York, March 26, 2026-- Moody's Ratings said that on 25 March, Merck& Co., Inc. announced that it entered into a definitive agreement to acquire Terns Pharmaceuticals, Inc. for approximately $5.7 billion net of acquired cash.
Moody's Ratings assigns Aa3 rating to Merck's sr. notes; stable outloo...
Moody's Ratings (Moody's) assigned a Aa3 rating to the new senior unsecured notes offering of Merck & Co., Inc. (Merck). There are no changes to Merck's existing ratings including the Aa3 senior unsecured long-term rating, the Aa3 senior unsecured revolving credit facility, the Aa3 backed senior uns...
Moody's Ratings says that Merck's acquisition of Cidara Therapeutics a...
Moody's Ratings (Moody's) said that on 14 November, Merck & Co., Inc. ("Merck"; Aa3 stable) announced that it entered into a definitive agreement to acquire Cidara Therapeutics, Inc. ("Cidara") for approximately $9.2 billion in cash. The acquisition meaningfully strengthens Merck's respiratory drug ...
Moody's Ratings assigns Aa3 rating to Merck's sr. notes; stable outloo...
Moody's Ratings (Moody's) assigned a Aa3 rating to the new senior unsecured notes offering of Merck & Co., Inc. ("Merck"). There are no changes to Merck's existing ratings including the Aa3 senior unsecured long-term rating, the Aa3 senior unsecured revolving credit facility, the Aa3 backed senior u...
Moody's Ratings says Merck's acquisition of Verona adds approved COPD ...
Moody's Ratings (Moody's) says that on 9 July, Merck & Co., Inc. ("Merck"; Aa3 stable) announced that it entered into a definitive agreement to acquire Verona Pharma plc ("Verona") for approximately $10 billion. The acquisition will meaningfully strengthen Merck's cardio-pulmonary product portfolio,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.